
Lifeloc Technologies, Inc. develops, manufactures, and markets portable hand-held and fixed station breathalyzers and related accessories for law enforcement, workplace, corrections, original equipment manufacturing, and consumer markets worldwide. It offers fuel-cell based breath alcohol testing equipment; and a line of supplies, accessories, services, and training to support customers' alcohol testing programs. The company also develops and sells online drug and alcohol training and refresher courses. In addition, it engages in the ownership and rental of real property through existing commercial leases. In addition, it provides breathalyzers, sentinel alcohol systems, R.A.D.A.R alcohol detection and reporting systems, calibration equipment, drug screen products, and impairment goggles, as well as alcomark breath testing management software. Lifeloc Technologies, Inc. serves to schools, oil and gas, military, and chiropractic industries. The company was incorporated in 1983 and is headquartered in Wheat Ridge, Colorado. Lifeloc Technologies, Inc. is a subsidiary of EDCO Partners LLLP.
Lifeloc Technologies, Inc. trades as LCTC on OTC. The company is classified in Technology / Hardware, Equipment & Parts and reports in USD.
The current profile places the business in Hardware, Equipment & Parts. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $9.03M of revenue and -$2.47M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Lifeloc Technologies, Inc. can be compared against peers such as AppYea, Inc., Global Warming Solutions, Inc., Edgewater Wireless Systems Inc., KwikClick, Inc., Paragon Technologies, Inc., RoboGroup T.E.K. Ltd..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $6.06M, beta of 0.61, and return on equity of -60.2%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
LCTC currently shows total debt of $1.83M and beta of 0.61. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
Recent filings to review: 8-K (2026-06-05 00:00:00), SD (2026-06-01 00:00:00), 8-K (2026-05-19 00:00:00), 10-Q (2026-05-14 00:00:00).
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.lifeloc.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.